Website Link - www.bpharmanotes.

com 1/18

om
ANTI-ANGINAL AND ANTI-

.c
es
ISCHEMIC DRUGS

ot
an
m
ar
ph
.b
w
w
w

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 2/18

Definitions
Ischemia: Is the inadequate blood supply to a part of the body,
even to the point of complete deprivation.

om
Ischemic heart disease (IHD): It is defined as acute or chronic

.c
form of cardiac disability arising from imbalance between

es
ot
between the myocardial supply and demand for oxygenated blood

an
eg. Angina pectoris and myocardial infarction .

m
ar
ph
Angina pectoris: It is a clinical syndrome of IHD resulting from
.b
w

transient myocardial ischemia.

w
w

It is characterized by pain in the substernal or pre-cordial region of

the chest which is aggravated by an increase in the demand of the
heart and relieved by decrease in the work of the heart. Often pain
radiated to left arm, neck, jaw or right arm.

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 3/18

om
.c
es
ot
an
m
ar
ph
.b
w
w
w

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 4/18

om
.c
es
ot
an
m
ar
ph
.b
w
w
w

Types of angina

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 5/18

Classification
1. Nitrates
a) Short acting: Glyceryl trinitrate (GNT, Nitogycerine)
b) Long acting: Isosorbide dinitrate, Isosorbide mononitrate,

om
Erythrityl tetranitrate

.c
2. β- blockers: Propranolol, Metoprolol, Atenolol

es
3. Calcium channel blockers

ot
an
a) Phenyl alkylamine: Verapamil

m
b) Benzothiazepine: Diltiazem
ar
ph
c) Dihyropyridines: Nifedipine, Nimodipine, Lacidipine,
.b
w

Lercanidipine, Benidipine
w

4. Potassium channel opener: Nicorandil

w

5. Others: Dipyridamole, Trimetazidine, Ranolazine, Ivabradine,

Oxyphendrine

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 6/18

Pharmacology of nitrates
Nitroglycerin
1. Preload reduction
2. After-load reduction

om
.c
3. Redistribution of coronary flow

es
4. Relief in angina

ot
an
Pharmacokinetics

m
ar
Nitrates are lipid soluble well absorbed from buccal mucosa,
ph
intestine and skin therapeutic nitrates and is available in forms
.b

that provide a range of durations of action from 10–20 min

w
w

(sublingual) to 8–10 h (transdermal).They undergo extensive first

w

past metabolism in liver. Rapidly denitrated by glutathione

reductase and mitochondrial aldehyde dehydrogenase.

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 7/18

om
.c
es
ot
an
m
ar
ph
.b
w
w
w

Mode of action of organic nitrates

Youtube Channel - Shadow Pharmacy World (Subscribe Now)
Website Link - www.bpharmanotes.com 8/18

Tolerance
1. Tolerance may result from a reduced capacity of the vascular
smooth muscle to convert nitroglycerin to NO
2. Multiple mechanisms have been proposed to account for
nitrate tolerance, including

om
.c
i) Volume expansion

es
ii) Neurohumoral activation

ot
an
iii) Cellular depletion of sulfhydryl groups, and the generation of

m
free radicals.
ar
ph
iv) Inactivation of mitochondrial aldehyde dehydrogenase, an
.b

enzyme implicated in biotransformation of nitroglycerin

w
w
w

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 9/18

Adverse drug reactions

The most common toxic effects of nitrates are the responses
evoked by vasodilation.
1. These include tachycardia (from the baroreceptor reflex)

om
.c
es
2. Orthostatic hypotension (a direct extension of the venodilator

ot
effect), and

an
m
ar
3. Throbbing headache from meningeal artery vasodilatation.
ph
.b
w
w

Drug interaction
w

Nitrates + Sildenafil can lead to severe hypotension, myocardial

infarction and death

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 10/18

Uses
1. Angina pectoris
2. Acute coronary syndromes
3. Myocardial infarction (MI)

om
4. CHF and acute LVF

.c
es
5. Biliary colic

ot
6. Esophageal spasm

an
m
7. Cynaide poisoning
ar
ph
.b
w
w
w

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 11/18

β- blockers
1. Adrenergic receptor antagonists are effective in reducing the
severity and frequency of attacks of exertional angina and in
improving survival in patients who have had an MI.

om
2. These agents are not useful for vasospastic angina and, if used

.c
in isolation, may worsen the condition.

es
3. Timolol, metoprolol, atenolol, and propranolol have been

ot
an
shown to exert cardioprotective effects. The effectiveness of

m
adrenergic receptor antagonists in the treatment of exertional
ar
angina is attributable primarily to a fall in myocardial O2
ph
.b
consumption at rest and during exertion,
w
w

4. The decrease in myocardial O2 consumption is due to a

w

negative chronotropic effect (particularly during exercise), a

negative inotropic effect, and a reduction in arterial blood
pressure (particularly systolic pressure) during exercise.

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 12/18

Calcium channel blockers

Mechanism of Action
1. Calcium channel blockers block voltage-gated L-type calcium
channels, the calcium channels most important in cardiac and

om
smooth muscle.

.c
2. By decreasing calcium influx during action potentials in a

es
frequency- and voltage-dependent manner, these agents

ot
an
reduce intracellular calcium concentration and muscle

m
contractility.
ar
ph
.b
w
w
w

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 13/18

om
.c
es
ot
an
m
ar
ph
.b
w
w
w

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 14/18

Adverse drug reactions

1. The calcium channel blockers cause constipation, pretibial
edema, nausea, flushing, and dizziness.
2. More serious adverse effects include heart failure, AV blockade,
and sinus node depression; these are most common with

om
verapamil and least common with the dihydropyridines.

.c
Use

es
1. Verapamil and Diltiazem may be used to treat AV nodal

ot
an
arrhythmia.

m
2. Calcium blockers are effective as prophylactic therapy in both
ar
ph
3. Effort and vasospastic angina.
.b
4. Nifedipine has also been used to abort acute anginal
w
w

5. In severe atherosclerotic angina, these drugs are particularly

w

valuable when combined with nitrates.

6. In addition to well-established uses in angina, hypertension, and
supraventricular tachycardia, some of these agents are used in
migraine, preterm labor, stroke, and Raynaud's phenomenon.
Youtube Channel - Shadow Pharmacy World (Subscribe Now)
Website Link - www.bpharmanotes.com 15/18

Potassium channel opener: Nicorandil

1.This a novel antianginal drug activates ATP sensitive K+
channels leading to hyperpolerization of vascular smooth
muscle.

om
2. It also acts as a NO donor and relaxes blood vessels by

.c
increasing cGMP.

es
ot
3. Coronary blood flow is increased, dilatation of both epicardial

an
conducting vessels and deeper resistance vessel.

m
ar
4. Mitochondrial K+ ATP channel opening exert myocardial
ph
protection by preconditioning which appears to reduce
.b

myocardial stunning, arrhythmias and infarct size.

w
w

Side effect
w

1. Flushing, palpitation, weakness, headache, dizziness

2. Large painful aphthous ulcers of mouth.

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 16/18

Newer Drugs
A) Ranolazine appears to act mainly by reducing a late,
prolonged sodium current in myocardial cells.
1. The decrease in intracellular sodium causes an increase in
calcium expulsion via the Na/Ca transporter and a reduction

om
in cardiac force and work.

.c
2. Ranolazine is moderately effective in angina prophylaxis.

es
ot
an
B) Dipyridamole

m
ar
1. It is a powerful coronary dilator; increases total coronary
ph
flow by preventing uptake and degradation of adenosine.
.b
w

2. It dilates resistance vessels and abolishes autoregulation.

w
w

3. Inhibit platelet aggregation.

4. Not useful as an anti-anginal drug but used for prophylaxis
of Coronary and cerebral thrombosis in post-MI and post
stoke patients.

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 17/18

C) Trimetazidine
1. It is a novel antianginal drug acts by nonhaemodynamic
mechanism.
2. Anginal frequency is reduced and exercise capacity is

om
increased.

.c
3. Mechanism of action not known .

es
ot
4. But may improve cellular tolerance to ischemia by

an
i) Inhibiting mitochondrial long chain 3-ketoacyl-CoA-

m
ar
thiolase (LC3-KAT) a key enzyme in fatty acid oxidation
ph
and increasing glucose metabolism in myocardium.
.b
w

ii) Limiting intracellular acidosis and Na+ and Ca++

w
w

accumulation during ischemia.

iii) Protecting against O. free radical induced membrane
damage

Youtube Channel - Shadow Pharmacy World (Subscribe Now)

Website Link - www.bpharmanotes.com 18/18

om
.c
es
ot
an
m
ar
ph
.b
w
w
w

Pharmacologic management of acute coronary syndromes

Youtube Channel - Shadow Pharmacy World (Subscribe Now)